Purpose: The 12/15-lipoxygenase (12/15-LOX) activity and the ceramide content are often elevated in neurodegenerative disorders; however their relationship in the brain is not established. To verify whether blocking of 12/15-LOX activity has an impact on ceramide pattern in the brain we inhibited the 12/15-LOX expression by administration of baicalein in mice. Materials and methods: The ceramides containing fatty acid methyl esters were analyzed using gas–liquid chromatography (GLC) technique. Results: The total ceramide content increased in baicalein-treated animals comparing to controls and the levels of most ceramide-fatty acids of SAFA, MUFA and PUFA tended to increase in relation to control. Baicalein treatment up-regulated significantly only the ceramide-lignoceric fatty acid in relation to controls. Conclusion: We have shown in this study that 12/15-LOX inhibition slightly alters the pattern of ceramides in the mouse brain.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.